Art: 714376-00M
Rev. Date: 31-Jan-12
14-11
Control solutions may also be stored at room temperature for up to 4 hours (18
to 30°C or 64 to
-
86°F). If left out longer than 4 hours at room temperature,
they should be discarded.
Directions for Use
Prior to testing, vials containing the lyophilized plasma and CaCl
2
reconstituting fluid should stand at room temperature 18-30ºC (64-86ºF) for a
minimum of 45 minutes. For best results, vials, cartridges, and analyzers should
be at the same temperature.
Reconstitute only one level of control plasma at a time. CONTROL SOLUTIONS
MUST BE USED IMMEDIATELY (less than 30 seconds) AFTER COMPLETING
THE RECONSTITUTION AND MIXING STEPS.
STEP
ACTION
1
After 45 minute room temperature equilibration, remove the cap
and stopper from one lyophilized human plasma control vial and
remove the cap from one vial of calcium chloride reconstituting
fluid.
2
Pour the entire contents of the calcium chloride vial into the
lyophilized human plasma control vial. Place the stopper back
in the reconstituted control vial, sealing the vial appropriately so
that the contents do not leak or spill out.
3
Allow the vial to sit at room temperature for 1 minute.
4
M i x t h e c o n t e n t s o f t h e v i a l b y s w i r l i n g g e n t l y
for 1 minute, then inverting slowly for 30 seconds.
Note
: To minimize foaming of the control sample, avoid vigorous
or rapid mixing motion. Visually inspect the control vial to ensure
that the sample is fully reconstituted. If not, discard and start
over with fresh vials.
5
Using a plastic transfer pipette, plastic syringe, or plastic
capillary tube with no anticoagulant, immediately transfer the
solution from the vial into the PT/INR cartridge.
6
Immediately seal the cartridge and insert it into an analyzer.
Note
: Additional PT/INR cartridges may be tested with
the remaining fluid if used within 30 seconds of complete
reconstitution of the sample.
Handle this product using the same safety precautions used when handling
any potentially infectious material. The human plasma used in the
preparation of this product has been tested by FDA approved test methods and
found negative/non-reactive for HIV-1, HIV-2, HBsAg, and HCV. However, no
known test method can offer complete assurance that products derived from
human blood will not transmit infectious disease.
Dispose of this product as biohazardous waste according to all local, state, and
national regulations.
Warnings and
Precautions
Control Target Values
and Expected Ranges
Target values (determined by testing multiple vials of each level using multiple
lots of i-STAT cartridges with analyzers that have passed the Electronic Simulator
test) are printed on a value assignment sheet posted on the APOC website at
www.abbottpointofcare.com. The ranges displayed represent the maximum
deviation expected when controls and cartridges are performing properly.
Should results outside the range be obtained, refer to the Troubleshooting
portion of this section of the i-STAT System Manual. Always be sure that the lot
number printed on the value assignment sheet matches the lot number on the
Summary of Contents for i-STAT 1
Page 1: ...i STAT 1 System Manual Rev Date 20 Jan 12 Art 714336 00L ...
Page 18: ...1 8 Art 714363 00U Rev Date 02 Aug 12 ...
Page 44: ......
Page 90: ......
Page 106: ...9 12 Art 714371 00E Rev Date 06 Aug 12 ...
Page 162: ......
Page 166: ...Art 730292 00A Rev Date 20 Feb 12 4 ...
Page 176: ...10 10 Art 714372 00L Rev Date 30 Jul 12 ...
Page 182: ...11 6 Art 714373 00F Rev Date 17 Jan 11 ...
Page 184: ...12 2 Art 714374 00J Rev Date 25 Aug 11 ...
Page 185: ...Art 714374 00J Rev Date 25 Aug 11 12 3 ...
Page 186: ...12 4 Art 714374 00J Rev Date 25 Aug 11 ...
Page 187: ...Art 714374 00J Rev Date 25 Aug 11 12 5 ...
Page 192: ......
Page 194: ......
Page 214: ...14 20 Art 714376 00M Rev Date 31 Jan 12 ...
Page 216: ...14 22 Art 714376 00M Rev Date 31 Jan 12 ...
Page 218: ...14 24 Art 714376 00M Rev Date 31 Jan 12 ...
Page 220: ...14 26 Art 714376 00M Rev Date 31 Jan 12 ...
Page 222: ...14 28 Art 714376 00M Rev Date 31 Jan 12 ...
Page 224: ...14 30 Art 714376 00M Rev Date 31 Jan 12 ...
Page 226: ......
Page 236: ......
Page 252: ...17 4 Art 714379 00F Rev Date 18 Jul 12 ...
Page 254: ......
Page 294: ...Art 725768 00E Rev Date 04 Jan 12 20 ...
Page 336: ...22 2 Art 714384 00D Rev Date 07 18 06 ...
Page 342: ...22 8 Art 714384 00D Rev Date 07 18 06 ...
Page 348: ...22 14 Art 714384 00D Rev Date 07 18 06 ...
Page 352: ...22 18 Art 714384 00D Rev Date 07 18 06 ...
Page 364: ...22 30 Art 714384 00D Rev Date 07 18 06 ...
Page 384: ...22 50 Art 714384 00D Rev Date 07 18 06 ...
Page 404: ...22 70 Art 714384 00D Rev Date 07 18 06 ...
Page 488: ...Kaolin ACT 4 Art 715878 00M Rev Date 31 Jan 12 ...
Page 536: ......
Page 556: ...Art 714261 00E Rev Date 10 Jan 11 8 ...
Page 560: ...Art 716240 00D Rev Date 03 Mar 10 4 ...
Page 572: ...Art 715617 00D Rev Date 06 11 08 ...
Page 578: ...Art 714547 00F Rev Date 06 11 08 ...
Page 590: ...Art 720735 00B Rev Date 06 11 08 ...
Page 592: ...Art 721106 00B Rev Date 06 11 08 ...
Page 598: ...Art 722831 00A Rev Date 19 Feb 09 ...
Page 610: ...Art 720654 00B Rev Date 06 11 08 ...
Page 614: ...Art 721317 00D Rev Date 13 Aug 12 4 ...
Page 616: ...Art 725703 00A Rev Date 08 Mar 10 2 ...
Page 618: ...Art 721296 00A Rev Date 07 16 08 ...
Page 620: ...REV DATE 16 Oct 12 ART 714446 00L ...
Page 627: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 6 REV DATE 16 Oct 12 ART 714446 00L ...
Page 628: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 7 REV DATE 16 Oct 12 ART 714446 00L ...
Page 629: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 8 REV DATE 16 Oct 12 ART 714446 00L ...
Page 630: ...PROCEDURE MANUAL FOR THE i STAT SYSTEM 9 REV DATE 16 Oct 12 ART 714446 00L ...
Page 658: ......